David Baram: Founder and CEO of EmendoBio

Portrait of David Baram

David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

Chemtura Brochure Cover
Chemtura Corporation

The Future Through Chemistry

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service